Thousand Oaks, CA, United States of America

Holly Zhuohong Huang

USPTO Granted Patents = 4 


 

Average Co-Inventor Count = 7.0

ph-index = 1

Forward Citations = 7(Granted Patents)


Company Filing History:


Years Active: 2014-2022

Loading Chart...
Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Holly Zhuohong Huang

Introduction

Holly Zhuohong Huang is a prominent inventor based in Thousand Oaks, California. She has made significant contributions to the field of pharmaceuticals, particularly in the development of antibody formulations for disease treatment. With a total of four patents to her name, her work has the potential to impact many lives.

Latest Patents

Holly's latest patents include a method of treating diseases using an IL-17 receptor antibody formulation. This patent relates to AM-14 pharmaceutical formulations and therapeutic dosing regimens for the treatment of various diseases. Another patent focuses on the IL-17 receptor antibody formulation, which also pertains to AM-14 pharmaceutical formulations and therapeutic dosing regimens.

Career Highlights

Throughout her career, Holly has worked with notable companies such as Kirin-Amgen, Inc. and Amgen K-A, Inc. Her experience in these organizations has allowed her to refine her skills and contribute to groundbreaking research in the pharmaceutical industry.

Collaborations

Holly has collaborated with esteemed colleagues, including Dingjiang Liu and David Andrew Martin. These partnerships have fostered an environment of innovation and creativity, leading to advancements in her field.

Conclusion

Holly Zhuohong Huang's contributions to pharmaceutical innovations through her patents and collaborations highlight her role as a leading inventor. Her work continues to pave the way for new treatments and therapies that can benefit many individuals.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…